Ran Nir‐Paz
- Microbiology top 0.5%
- Microbial infections and disease research 27
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 15
- Respiratory viral infections research 11
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 6
- Molecular Medicine top 5%
-
- Bacteriophages and microbial interactions 22
-
- Streptococcal Infections and Treatments 10
- Neonatal and Maternal Infections 8
-
- Genomics and Phylogenetic Studies 7
- Co-authors
- Allon E. MosesColin BlockCarlos Hidalgo‐GrassNadejda SigalAnat A. HerskovitsIlya BorovokRonen HazanAyelet Michael-Gayego
- Journals
- Clinical Microbiology and Infection (9 papers)Journal of Clinical Microbiology (4 papers)Emerging infectious diseases (4 papers)
- Partner nations
- IsraelUnited StatesFrance
In The Last Decade
Ran Nir‐Paz
92 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 122
- Microbiology 606
- Epidemiology 869
- Infectious Diseases 449
- Applied Microbiology and Biotechnology 42
- Molecular Medicine 88
Countries citing papers authored by Ran Nir‐Paz
This map shows the geographic impact of Ran Nir‐Paz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Nir‐Paz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Nir‐Paz more than expected).
Fields of papers citing papers by Ran Nir‐Paz
This network shows the impact of papers produced by Ran Nir‐Paz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Nir‐Paz. The network helps show where Ran Nir‐Paz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ran Nir‐Paz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 13 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 29 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 5 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 5 | |
| 11 | 2021 | 47 | |
| 12 | 2021 | 20 | |
| 13 | 2021 | 51 | |
| 14 | 2021 | 3 | |
| 15 | 2020 | 22 | |
| 16 | 2020 | 44 | |
| 17 | 2019 | 10 | |
| 18 | A Case Series of Emergency Investigational New Drug Applications for Bacteriophages Treating Recalcitrant Multi-drug Resistant Bacterial Infections: Confirmed Safety and a Signal of Efficacy | 2019 | 19 |
| 19 | 2014 | 26 | |
| 20 | 2009 | 13 |
About Ran Nir‐Paz
Ran Nir‐Paz is a scholar working on Microbiology, Applied Microbiology and Biotechnology, Infectious Diseases, Modeling and Simulation and Epidemiology, having authored 98 papers that have together received 2.2k indexed citations. Recurring topics across this work include Microbial infections and disease research (27 papers), Bacteriophages and microbial interactions (22 papers), Pneumonia and Respiratory Infections (15 papers), Respiratory viral infections research (11 papers), Streptococcal Infections and Treatments (10 papers), Neonatal and Maternal Infections (8 papers), Genomics and Phylogenetic Studies (7 papers) and Antimicrobial Resistance in Staphylococcus (6 papers). The work is most often cited by research in Microbiology (606 citations), Epidemiology (869 citations), Infectious Diseases (449 citations), Applied Microbiology and Biotechnology (42 citations) and Molecular Medicine (88 citations). Ran Nir‐Paz has collaborated with scholars based in Israel, United States and France. Frequent co-authors include Allon E. Moses, Colin Block, Carlos Hidalgo‐Grass, Nadejda Sigal, Anat A. Herskovits, Ilya Borovok, Ronen Hazan, Ayelet Michael-Gayego, Diana Averbuch and Dan Engelhard. Their work appears in journals such as Clinical Microbiology and Infection, Journal of Clinical Microbiology, Emerging infectious diseases, Open Forum Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.